| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2024 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 5,547 | $550.62 | $3,054,289.63 | -4.0% | +9.2% | -3.0% | |
| Feb 15, 2024 | CRL Charles River Laboratories International, Inc. | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 838 | $238.93 | $200,223.34 | -3.3% | -5.2% | -38.1% | |
| Feb 15, 2024 | NEO Neogenomics Inc | Olivo Alicia C69 | General Counsel | Sell | 2,587 | $14.96 | $38,712.90 | -6.9% | +1.5% | -3.2% | |
| Feb 15, 2024 | DHR Danaher Corp /de/ | Lohr Walter G51 | Director | Sell | 3,289 | $251.15 | $826,032.35 | -18.9% | +5.8% | -17.1% | |
| Feb 15, 2024 | CRL Charles River Laboratories International, Inc. | Parisotto Shannon M67 | Cevp, Disc &Safety Assessment | Sell | 5,882 | $241.20 | $1,418,766.99 | -13.5% | -5.2% | -38.1% | |
| Feb 15, 2024 | EXAS Exact Sciences Corp | Orville Jacob A76 | General Manager, Screening | Sell | 966 | $61.43 | $59,341.38 | -11.4% | -12.7% | -19.3% | |
| Feb 15, 2024 | EXAS Exact Sciences Corp | Condella Sarah75 | EVP, Human Resources | Sell | 965 | $61.43 | $59,279.95 | -1.4% | -12.7% | -19.3% | |
| Feb 15, 2024 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 14,791 | $61.43 | $908,611.13 | -1.2% | -12.7% | -19.3% | |
| Feb 15, 2024 | EXAS Exact Sciences Corp | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sell | 1,888 | $61.43 | $115,979.84 | -47.5% | -12.7% | -19.3% | |
| Feb 15, 2024 | EXAS Exact Sciences Corp | Herriott James75 | General Counsel | Sell | 421 | $61.43 | $25,862.03 | -6.1% | -12.7% | -19.3% | |
| Feb 15, 2024 | EXAS Exact Sciences Corp | Coward D Scott77 | Director | Sell | 1,376 | $61.43 | $84,527.68 | -3.2% | -12.7% | -19.3% | |
| Feb 13, 2024 | DHR Danaher Corp /de/ | Couchara Georgeann56 | SVP, Human Resources | Sell | 2,622 | $242.67 | $636,290.08 | -23.6% | +4.2% | -16.3% | |
| Feb 12, 2024 | TMO Thermo Fisher Scientific Inc. | Spar Debora L54 | Director | Sell | 164 | $546.97 | $89,703.08 | -12.0% | +8.0% | -0.3% | |
| Feb 12, 2024 | MTD Mettler Toledo International Inc/ | Finney Elisha W66 | Director | Sell | 251 | $1,177.35 | $295,514.85 | -44.3% | +22.8% | +11.9% | |
| Feb 12, 2024 | MTD Mettler Toledo International Inc/ | Kelly Michael A46 | Director | Sell | 1,268 | $1,175.00 | $1,489,895.92 | -9.9% | +22.8% | +11.9% | |
| Feb 12, 2024 | BDSX Biodesix Inc | Cowie Robin Harper62 | CFO, Sec'y &Treasurer | Sell | 18,855 | $1.80 | $33,946.21 | -5.1% | -7.9% | -42.4% | |
| Feb 12, 2024 | BDSX Biodesix Inc | Hutton Scott59 | President &CEO | Sell | 64,390 | $1.80 | $115,926.43 | -6.3% | -7.9% | -42.4% | |
| Feb 12, 2024 | BDSX Biodesix Inc | Pestano Gary Anthony65 | Chief Development Officer | Sell | 10,884 | $1.80 | $19,595.23 | -4.1% | -7.9% | -42.4% | |
| Feb 12, 2024 | BDSX Biodesix Inc | Vazquez Chris65 | Chief Accounting Officer | Sell | 1,999 | $1.80 | $3,599.03 | -9.1% | -7.9% | -42.4% | |
| Feb 12, 2024 | BDSX Biodesix Inc | O'Kane Kieran64 | Chief Commercial Officer | Sell | 11,731 | $1.80 | $21,120.35 | -7.7% | -7.9% | -42.4% | |
| Feb 8, 2024 | TWST Twist Bioscience Corp | Chess Robert84 | Director | Sell | 4,110 | $34.98 | $143,784.24 | -6.0% | +13.4% | +43.2% | |
| Feb 7, 2024 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 2,074 | $23.20 | $48,116.80 | -1.6% | +1.4% | +18.6% | |
| Feb 7, 2024 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 10,000 | $555.63 | $5,556,287.20 | -2.3% | +3.7% | +3.7% | |
| Feb 7, 2024 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 1,500,000 | $0.98 | $1,462,800.00 | +0.7% | +30.0% | +62.0% | |
| Feb 7, 2024 | TMO Thermo Fisher Scientific Inc. | Boxer Michael A59 | SVP And General Counsel | Sell | 14,566 | $562.00 | $8,186,092.00 | -53.0% | +3.7% | +3.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.